Last reviewed · How we verify
NCT04180189
An Intervention With Weighted Blankets for Children With ADHD and Sleep Problems
NA trial testing Weighted fiber blanket in Adhd in 100 participants. Completed in 30 June 2022.
30 June 2022
Quick facts
| Lead sponsor | Halmstad University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 January 2020 |
| Primary completion | 30 June 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Weighted fiber blanket
Conditions studied
- Adhd — all drugs for Adhd →
- Sleep Disturbance — all drugs for Sleep Disturbance →
Sponsor
Halmstad University
Who can join
Adults 6 to 13, any sex, with Adhd or Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate a sleep intervention with weighted blankets for children with ADHD and sleep problem regarding health-related outcomes, sleep, and cost-effectiveness. The study is an RCT with cross-over design. The participants will be randomized to start with an active or placebo blanket, and then change blankets during the 16 week study period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04180189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adhd
Currently open trials in the same condition.
- NCT03672266 — Studies of Brain and Body Interaction · recruiting
Other Halmstad University trials
Trials by the same sponsor.
- NCT06228417 — A Mobile App for Medication Adherence in Persons With Hypertension: a Pilot Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04180189 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Halmstad University
- Last refreshed: 1 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04180189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing